1-5 of 5
Martin Kornacker, MD
Close
Sort by
Journal Articles

Phase 1 Study of CD19 Targeted 4-1BBL Costimulatory Agonist to Enhance T Cell (Glofitamab Combination) or NK Cell Effector Function (Obinutuzumab Combination) in Relapsed/Refractory B Cell Lymphoma

Martin Hutchings, MD PhD, Fritz C. Offner, MD PhD, Francesc Bosch, MD PhD, Giuseppe Gritti, MD PhD, Carmelo Carlo-Stella, MD, Harriet Walter, William Townsend, MRCP,MDFRCPath, Franck Morschhauser, MD PhD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Sophie de Guibert, MD, Sylvia Herter, PhD, Koorosh Korfi, PhD, Veronica Craine, Sarah Louise Mycroft, Matt Whayman, Claudia Mueller, Natalie Dimier, PhD, Tom Moore, MBChB, Sara Belli, Martin Kornacker, MD, Katharina Lechner, Michael Dickinson, DMed Sci
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-136571
Published: 2020
Journal Articles

Open Label, Multicenter, Dose-Escalation/ Expansion Phase Ib Study to Evaluate Safety and Activity of BET Inhibitor RO6870810 (RO), Given As Monotherapy to Patients (pts) with Advanced Multiple Myeloma

Karthik Ramasamy, Ajay Nooka, MDMPH, Hang Quach, MDFRACP,FRCPA,MBBS, Myo Htut, MD, Rakesh Popat, Michaela Liedtke, MD, Sascha A Tuchman, MD, Jacob P. Laubach, MD, Cristina Gasparetto, MD, Asher A. Chanan-Khan, MD, Mark Hertzberg, MBBS PhDFRACP FRCPA, Mark Demario, MD MPH, Eveline Nueesch, PhD, Evelyne Chesne, PhD, Izolda Franjkovic, PhD, Katharina Lechner, Martin Kornacker, MD, Hearn Jay Cho, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–14.
https://doi.org/10.1182/blood-2020-136392
Published: 2020
Journal Articles

Treatment of Indolent Non-Hodgkin’s Lymphoma in Germany - Results of a Representative Population-Based Survey.

Martin Dreyling, MD, Sebastian Fetscher, MD, P. Kornek, MD, Arnd Nusch, MD, Martin Kornacker, MD, Ralf Angermund, MD, Harold Pliskat, MD, Lenka Kellermann, Thomas Kegel, MD
Journal: Blood
Blood (2007) 110 (11): 1353.
https://doi.org/10.1182/blood.V110.11.1353.1353
Published: 2007
Journal Articles

Bortezomib Retreatment in Relapsed Multiple Mycelia - A Retrospective Multicenter Survey.

Irena Hrusovsky, MD, Berthold Emmerich, MD, Monika Engelhardt, MD, Martin Kornacker, MD, Claudia-Nanette Gann, MD, Harold Pliskat, PhD, Georg Hess, MD
Journal: Blood
Blood (2007) 110 (11): 2720.
https://doi.org/10.1182/blood.V110.11.2720.2720
Published: 2007
Journal Articles

How Much Rituximab Do We Need: A Multicenter, Randomized Trial Comparing 1, 3 or 6 Infusions of Rituximab Added to 6 Cycles of CHOP Chemotherapy in Untreated Patients with Advanced Follicular Non-Hodgkins Lymphoma (HD2000-Trial).

Manfred Hensel, MD, Lars Scheuer, MD, Hans Salwender, MD, Juergen Finke, MD, Dieter Buerkle, MD, Heinz Albert Duerk, MD, Andreas Kaebisch, MD, Ralf Naumann, MD, Hans-Juergen Staiger, MD, Ingo Schmidt-Wolf, MD, Martin Kornacker, MD, Eugen Leo, MD, Joseph Fischer, MD, Anthony D. Ho, MD
Journal: Blood
Blood (2004) 104 (11): 4584.
https://doi.org/10.1182/blood.V104.11.4584.4584
Published: 2004